Cytokinetics, Incorporated
PublicCytokinetics, Incorporated is now publicly traded
The data on this page reflects Cytokinetics, Incorporated's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Angel
Apr 11, 2022
Total Funding Raised
$3M
Company Overview
Cytokinetics, Incorporated is a biopharmaceutical company that discovers, develops, and commercializes muscle activators and inhibitors to treat cardiovascular and neuromuscular diseases.
Sector
Biotech
AI Layer
Non-AI
Keywords
biopharmaceuticalbiotechmuscle activatorcardiac muscle therapyamyotrophic lateral sclerosisALShypertrophic cardiomyopathysmall-molecule drugdrug discoveryclinical trialscardiovascular diseaseneuromuscular diseasepharma stockbiotech pipeline
Cytokinetics, Incorporated Comparables
Compare Cytokinetics, Incorporated with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DalCor Pharmaceuticals | 56% | |
| Revier Therapeutics | 45% |
Cytokinetics, Incorporated Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Apr 11, 2022 |
Cytokinetics, Incorporated Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFirmographic Details
HeadquartersSouth San Francisco, California
Employee Range18
Year Founded1997
Last FundingApr 11, 2022
See something wrong or outdated?